CCDC166: A Drug Target / Disease Biomarker (G100130274)

Target Name: CCDC166

NCBI ID: G100130274

CCDC166

Other Name(s): coiled-coil domain containing 166 | Coiled-coil domain-containing protein 166 | CC166_HUMAN | Coiled-coil domain containing 166

CCDC166: A Drug Target / Disease Biomarker

CCDC166 is a protein that is expressed in various tissues throughout the body. It is a key regulator of cell division and has been identified as a potential drug target in the treatment of various diseases.

CDC166 is a member of the superfamily of core transcription factors, which are a group of transcription factors that play a central role in the regulation of gene expression. These factors include DNA-binding proteins, RNA-binding proteins, and protein-coding genes. CDC166 is a RNA-binding protein that is expressed in various tissues throughout the body, including the brain, heart, and gastrointestinal tract.

One of the key functions of CDC166 is its role in cell division. It is a transcription factor that is involved in the regulation of mitosis, meiosis, and cell division in various organisms. In addition, CDC166 is also involved in the regulation of apoptosis, which is a natural process that helps to remove damaged or dysfunctional cells from the body.

CDC166 has been identified as a potential drug target in the treatment of various diseases, including cancer, neurodegenerative diseases, and developmental disorders. One of the reasons for its potential as a drug target is its involvement in the regulation of cell division and its ability to be targeted with small molecules.

In cancer, CDC166 has been shown to be involved in the regulation of cell division and has been identified as a potential therapeutic target for various types of cancer, including breast, ovarian, and colorectal cancer. Studies have shown that inhibiting the activity of CDC166 can lead to the growth inhibition and apoptosis of cancer cells.

In neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease, CDC166 has been shown to be involved in the regulation of neurogenesis and the maintenance of neuronal stem cells. Therefore, it is a potential target for neurodegenerative diseases.

In addition to its potential therapeutic applications, CDC166 has also been identified as a potential biomarker for various diseases. The expression of CDC166 has been shown to be associated with various diseases, including cancer, neurodegenerative diseases, and developmental disorders. Therefore, it may be a useful biomarker for the diagnosis and monitoring of these diseases.

In conclusion, CDC166 is a protein that is expressed in various tissues throughout the body and is involved in the regulation of cell division and apoptosis. Its potential as a drug target and biomarker make it an attractive target for the development of new treatments for various diseases. Further research is needed to fully understand the role of CDC166 in disease and to develop safe and effective treatments.

Protein Name: Coiled-coil Domain Containing 166

The "CCDC166 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCDC166 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets